Cargando…
Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT
BACKGROUND: Insulin resistance and hyperinsulinemia may play a role in pathogenesis of PCOS. One of the common therapeutic methods is using insulin-sensitizing drugs such as metformin and thiazolidinediones. OBJECTIVE: The purpose was to determine the effect of metformin and pioglitazone on clinical...
Autores principales: | Sohrevardi, Seyed Mojtaba, Nosouhi, Fahime, Hossein Khalilzade, Saeed, Kafaie, Parichehr, Karimi-Zarchi, Mojgan, Halvaei, Iman, Mohsenzadeh, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203689/ https://www.ncbi.nlm.nih.gov/pubmed/28331909 |
Ejemplares similares
-
Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis
por: Karimi-Zarchi, Mojgan, et al.
Publicado: (2016) -
Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016) -
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023) -
Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
por: Vinaixa, Maria, et al.
Publicado: (2011) -
Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation
por: Kabiri, Nahid, et al.
Publicado: (2014)